Patent · US Active

Analysis of ubiquitinated polypeptides

US11352418B2 · kind B2 · utility

0Cited by
27References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2019
Grant dateJun 7, 2022
Priority date
Expiry dateJul 11, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure relates to antibody reagents that specifically bind to peptides carrying a ubiquitin remnant from a digested or chemically treated biological sample. The reagents allow the technician to identify ubiquitinated polypeptides as well as the sites of ubiquitination on them. The reagents are preferably employed in proteomic analysis using mass spectrometry. The antibody reagents specifically bind to the remnant of ubiquitin (i.e., a diglycine modified epsilon amine of lysine) left on a peptide which as been generated by digesting or chemically treating ubiquitinated proteins. The inventive antibody reagents' affinity to the ubiquitin remnant does not depend on the remaining amino acid sequences flanking the modified (i.e., ubiquitinated) lysine, i.e., they are context independent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.